Statistics for Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial
Total visits
| views | |
|---|---|
| Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial | 23 |
Total visits per month
| views | |
|---|---|
| November 2024 | 3 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
File Visits
| views | |
|---|---|
| Adams-2023-Efficacy-and-safety-of-vutrisiran-f.pdf(legacy) | 5 |
| Adams-2023-Efficacy-and-safety-of-vutrisiran-f.pdf | 2 |
Top country views
| views | |
|---|---|
| United States | 11 |
| Australia | 3 |
| Argentina | 2 |
| China | 2 |
| Germany | 2 |
| Israel | 1 |
| Portugal | 1 |
| Ukraine | 1 |